FTD To Buy Provide Commerce for $430 Million

Related Link: 

FTD Cos. agrees to buy the Provide Commerce flower and gifting businesses from Liberty Interactive for $430 million in cash and stock.

Hess Plans Spinoff of Assets

Related Link: 

Hess said it plans to pursue a spinoff of some midstream assets, mostly in North Dakota, to create a separately traded company to support growth of its production in the Bakken oil shale play.

Telefónica Circles Mexican Rival

Related Link: 

Telefónica said it is in talks to buy a Mexican rival, reported to be Iusacell, in a deal that could be worth as much as $4 billion.

Mixed Fortunes for European Car Makers

Related Link: 

European car makers painted a murky portrait of the global auto industry as concerns about Russia and Latin America blunt the optimism fueled by a steady rebound in European auto demand.

Goodyear Profit Rises on North America Sales

Related Link: 

Goodyear Tire reported a nearly 18% jump in its second-quarter profit as sales in North America, combined with some cost squeezing in Europe, offset the economic softness in other parts of the world.

Hospira Profit More Than Doubles

Related Link: 

Hospira Inc. said its second-quarter profit more than doubled, as the provider of injectable drugs and infusion technologies posted higher sales.

Phillips 66 Profit Falls

Related Link: 

Phillips 66said its second-quarter earnings fell 9.9% amid weaker refining earnings, partly offset by growth in its chemicals segment.

Dominion Resources Profit Falls 21%

Related Link: 

Dominion Resources said its second-quarter earnings declined 21%, dented by milder weather and a one-time legislation-related charge.

Peugeot Car Unit Returns to Profit

Related Link: 

Stiff cost cuts helped French car maker Peugeot Citroën's automobile unit to nose back into the black in the first half for the first time in three years, paring the overall company's losses amid rising sales in Europe and China.

Pfizer To Buy Baxter's Vaccines

Related Link: 

Pfizer said it has agreed to acquire Baxter's portfolio of marketed vaccines for $635 million.

Syndicate content